Concepedia

Omar Alhalabi

OA

Statistics

Publications

29

Citations

1.5K

H-Index

17

Active since

2014

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Emory University

Dana-Farber Cancer Institute

The University of Texas Health Science Center at Houston

Baylor College of Medicine

Omar Alhalabi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2014–2025

29

Publications

29

Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

Jianjun Gao, Neema Navai, Omar Alhalabi et al. · Nature Medicine · 2020 · 313 citations · Full text

, , +14

9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

Guangchun Han, Guoliang Yang, Dapeng Hao et al. · Nature Communications · 2021 · 224 citations · Full text

, , +17

Factor XII and uPAR upregulate neutrophil functions to influence wound healing

Evi X. Stavrou, Chao Fang, Kara L. Bane et al. · Journal of Clinical Investigation · 2018 · 141 citations · Full text

, , +17

Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016

Ahmed O. Elmehrath, Ahmed Afifi, Muneer J. Al‐Husseini et al. · JAMA Network Open · 2021 · 117 citations · Full text

, , +17

Reduced thrombosis in Klkb1−/− mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor

Evi X. Stavrou, Chao Fang, Alona Merkulova et al. · Blood · 2014 · 86 citations · Full text

, , +13

1–5 of 29